Orthofix Medical (OFIX) Operating Expenses (2010 - 2026)

Orthofix Medical has disclosed Operating Expenses across 17 years of filings, most recently posting $150.2 million for Q1 2026.

• Quarterly Operating Expenses fell 1.65% year-over-year to $150.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $617.7 million (up 86.34% YoY) and the FY2025 annual result came in at $620.2 million, up 0.75% from the prior year.
• Operating Expenses slipped to $150.2 million in Q1 2026, from $152.1 million in the prior quarter.
• Over five years, Operating Expenses peaked at $440.2 million in Q4 2023 and troughed at $9.5 million in Q3 2023.
• A 5-year average of $118.3 million and a median of $150.2 million in 2026 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2023 — Operating Expenses slumped 69.46% — and 2025, when it soared 1396.2%.
• Tracing OFIX's Operating Expenses over 5 years: stood at $267.4 million in 2022, then soared by 64.61% to $440.2 million in 2023, then tumbled by 64.43% to $156.6 million in 2024, then slipped by 2.86% to $152.1 million in 2025, then declined by 1.25% to $150.2 million in 2026.
• Business Quant data shows OFIX's Operating Expenses at $150.2 million in Q1 2026, $152.1 million in Q4 2025, and $162.9 million in Q3 2025.